TidalSense

Developer of AI-driven respiratory diagnostic and monitoring technologies. The company's technologies are built on a foundation of a novel sensor technology (N-Tidal) that is able to detect changes in lung function quickly and accurately. N-Tidal converts sensor data into (novel) respiratory biomarkers in near-real-time (minutes). Data is managed automatically and the device is 4G connected, handheld, portable and has high patient acceptability. Using these biomarkers, the company has built an affordable AI-driven diagnostic test for COPD which automates testing and interpretation in under 5 minutes (compared to the clinical standard 30 minutes).

TidalSense headquartered in Europe, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $871.9M in funding across 64 round(s). With a team of 11-50 employees, TidalSense is actively contributing to advancements in Biotechnology. Their latest funding round, Pre Seed Round - TidalSense, raised $883.5K. Discover more about their projects, partnerships, and impact on our platform.